𝔖 Bobbio Scriptorium
✦   LIBER   ✦

P299 Is neoadjuvant chemotherapy in breast cancer increasing?

✍ Scribed by B. Sancho Perez; M. Gallego; M.C. Sanz; M.L. Arroyo; S. Aragón; M. Blanco; P. Manosalvas; E. Ciruelos; L. Manso; J.M. Hérnandez

Book ID
114316636
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
36 KB
Volume
20
Category
Article
ISSN
0960-9776

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Neoadjuvant chemotherapy in breast cance
Neoadjuvant chemotherapy in breast cancer
✍ H. Charfare; S. Limongelli; A. D. Purushotham 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB 👁 2 views
Stage III breast cancer: Is neoadjuvant
Stage III breast cancer: Is neoadjuvant chemotherapy always necessary?
✍ James L. Frank; Donna K. McClish; Kathy S. Dawson; Harry D. Bear 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 539 KB

Optimal management of locally advanced breast cancer is controversial. Claims of superiority for neoadjuvant systemic therapy are based on comparisons with outdated historical control groups who received no chemotherapy. Between 1978 and 1987, 118 patients with locally advanced breast cancer underwe

Neoadjuvant chemotherapy in locally adva
Neoadjuvant chemotherapy in locally advanced breast cancer
✍ Singh, Gurpreet; Singh, Deepinder P.; Gupta, Devender; Muralikrishna, Bhavaraju 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 403 KB 👁 2 views

Thirty-eight patients with locally advanced breast cancer (Stage HI) were treated over a 3-year period. All patients initially received two cycles of CMF (cyclophosphamide, 100 mg/m2 p.0. dl-14; methotrexate 40mg/m2 intravenously (iv), d l and d8., 5 Fluorouracil 500 mg/m2 iv d l and d8). They were